KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Share-based Compensation (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Share-based Compensation data on record, last reported at $24.1 million in Q4 2025.

  • For Q4 2025, Share-based Compensation rose 14.22% year-over-year to $24.1 million; the TTM value through Dec 2025 reached $90.2 million, down 10.69%, while the annual FY2025 figure was $90.2 million, 10.69% down from the prior year.
  • Share-based Compensation reached $24.1 million in Q4 2025 per ZBH's latest filing, down from $25.3 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $33.9 million in Q2 2023 and bottomed at $14.9 million in Q4 2021.
  • Average Share-based Compensation over 5 years is $23.6 million, with a median of $24.3 million recorded in 2024.
  • Peak YoY movement for Share-based Compensation: surged 79.87% in 2022, then plummeted 43.07% in 2023.
  • A 5-year view of Share-based Compensation shows it stood at $14.9 million in 2021, then soared by 79.87% to $26.8 million in 2022, then dropped by 5.6% to $25.3 million in 2023, then decreased by 16.6% to $21.1 million in 2024, then increased by 14.22% to $24.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Share-based Compensation were $24.1 million in Q4 2025, $25.3 million in Q3 2025, and $21.2 million in Q2 2025.